Patents by Inventor Yunpeng Qi

Yunpeng Qi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CD20 ANTIBODY FORMULATION AND USE OF ANTI-CD20 ANTIBODY FOR TREATMENT OF CD20 POSITIVE DISEASES
    Publication number: 20230338526
    Abstract: Disclosed are anti-CD20 antibody formulations and use of anti-CD20 antibodies for the treatment of CD20 positive diseases, such as methods of using anti-CD20 antibodies for treating CD20 positive diseases, such as neuromyelitis optica spectrum disorders (NMOSD), non-Hodgkin's lymphoma (NHL), multiple sclerosis (MS), immune thrombocytopenia (ITP), rheumatoid arthritis (RA), Wegener's granulomatosis (WG), microscopic polyangiitis (MPA), lupus nephritis, systemic lupus erythematosus and chronic lymphocytic leukemia (CLL).
    Type: Application
    Filed: October 12, 2020
    Publication date: October 26, 2023
    Inventors: Yanyu CHEN, Yong WU, Yuanqing ZHOU, Chao QIN, Cuizhen XIAO, Zhihao WU, Dandan HUANG, Yujie LIU, Shengwu WANG, Cuihua LIU, Yunpeng QI, Jin-Chen YU, Li ZHANG, Shengfeng LI
  • Indenoquinolone compound, preparation method and use thereof
    Patent number: 9181193
    Abstract: An indenoquinolone compounds of Formula (A) is disclosed, wherein the definition of each group is described in the description. These compounds may specifically inhibit topoisomerase I, and they have good activities against many kinds of human tumor cells, such as lung cancer, colon cancer, breast cancer, liver cancer and the like. They can be used in the manufacture of antitumor drugs. The method for preparing the compound of formula (A), and pharmaceutical compositions containing such compounds and the use in the manufacture of antitumor drugs are also disclosed.
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: November 10, 2015
    Assignee: Second Military Medical University, PLA
    Inventors: Yunlong Song, Xiaodan Fu, Yunpeng Qi, Yves G. Pommier
  • INDENOQUINOLONE COMPOUND, PREPARATION METHOD AND USE THEREOF
    Publication number: 20130102598
    Abstract: An indenoquinolone compounds of Formula (A) is disclosed, wherein the definition of each group is described in the description. These compounds may specifically inhibit topoisomerase I, and they have good activities against many kinds of human tumor cells, such as lung cancer, colon cancer, breast cancer, liver cancer and the like. They can be used in the manufacture of antitumor drugs. The method for preparing the compound of formula (A), and pharmaceutical compositions containing such compounds and the use in the manufacture of antitumor drugs are also disclosed.
    Type: Application
    Filed: May 17, 2011
    Publication date: April 25, 2013
    Applicant: SECOND MILITARY MEDICAL UNIVERSITY, PLA
    Inventors: Yunlong Song, Xiaodan Fu, Yunpeng Qi